Purchase of HPV genotyping assays and testing supplies in support of research efforts for the national cancer institutes (NCI), division of cancer epidemiology and genetics (DCEG).
Ended Purchase Order Awarded
- Contract number
- 75N91021P00756
- Awardee
-
Atila Biosystems Incorporated UEI YRMLK9B1GHM4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $95,995
Award facts
- Opportunity
-
- Amendment #0001 - Purchase of HPV Genotyping Assays and Testing Supplies Solicitation · 75N91021Q00171 · Posted Jul 30, 2021
- Contract value 100% obligated
- $95,995.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Palo Alto, CA 94306, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, with an ID of 75N91021P00756, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $95,995 firm-fixed-price purchase order was awarded to Atila Biosystems Incorporated, a small business, to provide HPV genotyping assays and testing supplies to support the NCI's Division of Cancer Epidemiology and Genetics (DCEG) research efforts. The contract was designated as a Total Small Business set-aside, referencing the North American Industry Classification System (NAICS) code 325413 for In-Vitro Diagnostic Substance Manufacturing. This contract award was made under a prior $5.03 million grant awarded to Atila Biosystems by the NCI for a project related to the prevention of cervical cancer using HPV genotyping and same-day screening and treatment.
Quick answers
Who was awarded contract 75N91021P00756?
75N91021P00756 was awarded to Atila Biosystems Incorporated by National Cancer Institute (National Institutes of Health) on September 2, 2021.
How much is contract 75N91021P00756 worth?
The government has obligated $95,995 on 75N91021P00756.
Was contract 75N91021P00756 competed?
The extent of competition for 75N91021P00756 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award